Progresses and Challenges of Fast Dissolving/Disintegrating Dosage Forms in Manufacturing, Formulation Screening, Preclinical Testing and Drug Delivery
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Recent patents on drug delivery & formulation - 14(2020), 1 vom: 03., Seite 3-4 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Saharan, Vikas Anand [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 01.11.2023 Date Revised 01.11.2023 published: Print Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2174/187221131401200609144457 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316243086 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316243086 | ||
003 | DE-627 | ||
005 | 20231225160651.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/187221131401200609144457 |2 doi | |
028 | 5 | 2 | |a pubmed24n1054.xml |
035 | |a (DE-627)NLM316243086 | ||
035 | |a (NLM)33054701 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Saharan, Vikas Anand |e verfasserin |4 aut | |
245 | 1 | 0 | |a Progresses and Challenges of Fast Dissolving/Disintegrating Dosage Forms in Manufacturing, Formulation Screening, Preclinical Testing and Drug Delivery |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.11.2023 | ||
500 | |a Date Revised 01.11.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Editorial | |
773 | 0 | 8 | |i Enthalten in |t Recent patents on drug delivery & formulation |d 2007 |g 14(2020), 1 vom: 03., Seite 3-4 |w (DE-627)NLM18511380X |x 2212-4039 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2020 |g number:1 |g day:03 |g pages:3-4 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/187221131401200609144457 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2020 |e 1 |b 03 |h 3-4 |